France

5 Vaccines Approved for Use in France

Protein Subunit

Novavax

Nuvaxovid

Approved in 37 countries
16 trials in 12 countries
Approval Source: ema.europa.eu
RNA

Moderna

Spikevax

Approved in 86 countries
67 trials in 23 countries
Approval Source: ema.europa.eu
RNA

Pfizer/BioNTech

Comirnaty

Approved in 146 countries
84 trials in 27 countries
Approval Source: ema.europa.eu
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Approval Source: ema.europa.eu
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 140 countries
64 trials in 31 countries
Approval Source: ema.europa.eu

6 in Clinical Trials in France

Protein Subunit

Sanofi/GSK

Recombinant Protein

6 trials in 7 countries
Protein Subunit

Sanofi/GSK

SP/GSK subunit B.1.351 vaccine

2 trials in 1 country
Protein Subunit

Sanofi/GSK

SP/GSK subunit D614 vaccine

RNA

Pfizer/BioNTech

Comirnaty

Approved in 146 countries
84 trials in 27 countries
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Non Replicating Viral Vector

ReiThera

GRAd-COV2

5 trials in 12 countries

2 Vaccines with Trials in France are No Longer Progressing

RNA

Curevac

CVnCoV

9 trials in 12 countries
Replicating Viral Vector

Institut Pasteur

COVID-19-101